11 March 2026
Zotefoams plc
("Zotefoams" or "Group")
Preliminary results presentation
11 March 2026 - Zotefoams, a world leader in high-performance foams, is pleased to announce that Ronan Cox, Group CEO, and Nick Wright, Group CFO, will provide a live presentation relating to the 2025 Preliminary Results via Investor Meet Company on 17 Mar 2026, 13:30 GMT.
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 17 Mar 2026, 09:00 GMT, or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet ZOTEFOAMS PLC via: https://www.investormeetcompany.com/zotefoams-plc/register-investor
Investors who already follow ZOTEFOAMS PLC on the Investor Meet Company platform will automatically be invited.
Enquiries:
|
Zotefoams plc |
+44 (0) 208 664 1600 |
|
Ronan Cox, Group CEO |
|
|
Nick Wright, Group CFO
|
|
|
IFC Advisory |
+44 (0) 203 934 6630 |
|
Graham Herring Tim Metcalfe Zach Cohen |
|
About Zotefoams plc
Zotefoams plc (LSE - ZTF) is a world leader in high-performance foam technology, delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide across three market verticals, Consumer & Lifestyle, Transport & Smart Technologies, and Construction & Other Industrial. Zotefoams uses its own materials to manufacture T-FIT® advanced insulation for demanding industrial markets.
Zotefoams is headquartered in London, UK, with manufacturing sites in Croydon, UK, Kentucky, USA, Brzeg, Poland (foam manufacture), Anglesola and Burgos, Spain, and foam products conversion in Oklahoma, USA and Jiangsu Province, China (T-FIT).
AZOTE®, ZOTEK®, and T-FIT® are registered trademarks of Zotefoams plc.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
